Hosted on MSN6mon
Roche Jumps After Weight-Loss Pill Shows Promise in Study
(Bloomberg) -- Roche Holding AG shares jumped after its experimental weight loss pill showed meaningful weight reduction in an early stage study among obesity patients, setting up the Swiss ...
pharmaphorum6d
Roche's MS drug Ocrevus priced in line with Novartis rival in UK
In an interview with pharmaphorum, Marius Scholtz, country medical lead for Roche UK, said the drug will have around the same yearly cost in relapsing disease as Novartis’ once-daily pill ...
Hosted on MSN6mon
Weight Loss Pills Intensify Obesity Drug Race—But Here’s Why Experts Say Injections Aren’t Going Anywhere
Lilly and Pfizer are both working on promising once-daily pills, orforglipron and danuglipron, and Roche has touted promising results from two candidates in early-stage trials. MORE FROM ...
Reuters29d
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
ZURICH, Jan 8 (Reuters) - Roche (ROG.S), opens new tab on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics (PSTX.O), opens new tab ...